ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CAR:T – Has biology outpaced the ability to deliver? – pharmaphorum

Continue reading

2017-12-08 Michael Zand NEWS

At a CAGR Of 19.9% Synthetic Biology Market $8.84 Billion By 2022 – Market By Tool, Technology, Application, Industry – Medgadget (blog)

First News ServiceAt a CAGR Of 19.9% Synthetic Biology Market $8.84 Billion By 2022 – Market By Tool, Technology, Application, IndustryMedgadget (blog)Based on technology, the synthetic biology market is segmented into gene synthesis, genome engineerin… Continue reading

2017-12-08 Michael Zand NEWS

More Mutations in Melanoma Cells Predict Better Responses to Immunotherapy – Immuno-Oncology News

Immuno-Oncology NewsMore Mutations in Melanoma Cells Predict Better Responses to ImmunotherapyImmuno-Oncology NewsAlthough the treatment outcomes are promising, only a limited number of melanoma patients (fewer than 50 percent) respond to this type of … Continue reading

2017-12-08 Michael Zand NEWS

ERC grant: €2 million for synthetic biology at TU Darmstadt – EurekAlert (press release)

ERC grant: €2 million for synthetic biology at TU DarmstadtEurekAlert (press release)This will further strengthen the activities of TU Darmstadt in the domain of synthetic biology. The prestigious ERC Consolidator Grant for Heinz Koeppl is linked to th… Continue reading

2017-12-08 Michael Zand NEWS

CRISPR: The Latest Edition – Science Magazine (blog)

CAR:T – Has biology outpaced the ability to deliver?
pharmaphorum
Adapter CAR Program Manager. “The use of universal T cells might be the right tool to overcome shortage? First trials are promising…There’s emerging of companies doing exciting work with using renewable master to develop pluripotent stem cell lines …

Continue reading

2017-12-08 Michael Zand NEWS

VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells … – Marketwired (press release)

VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells …Marketwired (press release)SOUTH SAN FRANCISCO, CA–(Marketwired – December 08, 2017) – VistaGen Therapeutics Inc. ( NASDAQ : VTGN), a c… Continue reading

2017-12-08 Michael Zand NEWS

VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells … – Marketwired (press release)

VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New US Patent on Methods for Producing Blood Cells …Marketwired (press release)SOUTH SAN FRANCISCO, CA–(Marketwired – December 08, 2017) – VistaGen Therapeutics Inc. ( NASDAQ : VTGN), a c… Continue reading

2017-12-08 Michael Zand NEWS

CRISPR gene-editing technology expected to accelerate crop development – Genetic Literacy Project

CRISPR gene-editing technology expected to accelerate crop developmentGenetic Literacy ProjectIn the future, gene editing technology, particularly the technique called Crispr, is expected to accelerate the introduction of new crops. This involves makin… Continue reading

2017-12-08 Michael Zand NEWS
  • 1
  • …
  • 815
  • 816
  • 817
  • 818
  • 819
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Los Angeles Times

CRISPR: The Latest Edition
Science Magazine (blog)
There’s a rather large breakthrough in CRISPR gene editing – yeah, another one – that has downstream implications for drug discovery. A group at the Salk Institute reports in Cell that they’ve found a way to do both loss- and gain-of-function without …
Scientists use CRISPR to turn genes on without editing their DNALos Angeles Times
CRISPR/Cas9 Edits Epigenome with Therapeutic EfficiencyGenetic Engineering & Biotechnology News
Diabetes and muscular dystrophy could be treated effectively with modified Crispr genetic engineering techniqueThe Independent
Futurism –New Atlas –The Guardian
all 42 news articles »